Drug intelligence / Profile preview

Beclovid-C

Development stage
Unknown
Lead developer
Hovid
Modality
Small Molecules
Administration
Topical
01

Overview

Beclovid-C is a topical combination cream manufactured by the Malaysian pharmaceutical company Hovid. It is formulated with three active ingredients: clotrimazole (1%), beclomethasone dipropionate (0.025%), and neomycin. This combination is indicated for the treatment of various inflammatory skin disorders complicated by bacterial and/or fungal infections. Beclomethasone dipropionate is a corticosteroid that reduces inflammation, redness, and itching by activating glucocorticoid receptors. Clotrimazole is a broad-spectrum antifungal agent that inhibits the synthesis of ergosterol, thereby disrupting fungal cell membrane integrity. Neomycin is an aminoglycoside antibiotic that prevents bacterial growth by binding to the 30S ribosomal subunit and inhibiting protein synthesis. The product is marketed for topical application to affected skin areas.

Brand names
Beclovid-C
Other names
Beclovid-C Creamclotrimazole + beclomethasone dipropionate + neomycin
02

Targets

Bacterial RibosomeCYP51A1 (Sterol 14α-demethylase)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Beclovid-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beclovid-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call